Last reviewed · How we verify
NCT07456514: MM
Feasibility and Acceptability of a Co-produced Intervention to Improve Physical Activity and Motor Competence Amongst Children With Intellectual Disabilities and/or Autism Spectrum Disorder: Movement Matters
trial testing Movement Matters in Physical Activity in 43 participants. Completed in 14 July 2023.
14 July 2023
Quick facts
| Lead sponsor | Liverpool John Moores University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 16 March 2022 |
| Primary completion | 14 July 2023 |
| Estimated completion | 14 July 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Movement Matters
Conditions studied
- Physical Activity — all drugs for Physical Activity →
- Motor Skills Development — all drugs for Motor Skills Development →
Sponsor
Liverpool John Moores University
Who can join
Adults 7 to 11, any sex, with Physical Activity or Motor Skills Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to find out whether an intervention designed to improve physical activity levels and movement skills is practical and acceptable for children aged 7-11 years with intellectual disabilities and/or autism spectrum disorder. The intervention will be designed with input from people with lived experience, including professionals working in schools, physical education, sport, health services, and charities, as well as parents and families. The study will explore whether this type of intervention can be realistically delivered in special educational needs schools as part of their usual day-to-day activities. The main question the study aims to answer is: • Is an intervention to improve physical activity and motor skills feasible and acceptable for special educational needs schools? Participating schools will implement the intervention for six weeks. Several outcomes related to feasibility and acceptability will be measured to understand how well the intervention works in a school setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07456514
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting
Other Liverpool John Moores University trials
Trials by the same sponsor.
- NCT07454317 — Biofeedback Intervention for Paroxysmal Atrial Fibrillation · NA · not yet recruiting
- NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
- NCT07366931 — The Effect of Daily Supplementation With Humiome® Post LB on Gastrointestinal Symptoms in Female Athletes · Phase 1, PHASE2 · not yet recruiting
- NCT07466732 — Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males · EARLY_PHASE1 · enrolling by invitation
- NCT07341243 — Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07456514 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liverpool John Moores University
- Last refreshed: 6 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07456514.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing